Code | 3579C | ||||||||||
MA number | EU/1/16/1164/001 | ||||||||||
Product Form: | sol inj 1x0,4 ml/20 mg (striek.inj.skl.napl.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Amgen Europe B.V., Netherland | ||||||||||
Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Subcutaneous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 10(4) similar biological application |
MA issued: | 22.03.2017 |
SmPC + PL: |
|
Safety feature | Yes |
Data update: | 19.07.2024 |